Central Pacific Bank Trust Division Sells 1,460 Shares of Doximity, Inc. (NASDAQ:DOCS)

Central Pacific Bank Trust Division lessened its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 39.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 2,280 shares of the company’s stock after selling 1,460 shares during the quarter. Central Pacific Bank Trust Division’s holdings in Doximity were worth $122,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. FMR LLC raised its holdings in Doximity by 30.5% in the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after acquiring an additional 1,598,602 shares during the period. William Blair Investment Management LLC increased its stake in shares of Doximity by 15.8% during the second quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company’s stock worth $179,122,000 after purchasing an additional 873,682 shares during the period. Clearbridge Investments LLC increased its stake in shares of Doximity by 7.1% during the second quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company’s stock worth $163,709,000 after purchasing an additional 387,200 shares during the period. State Street Corp lifted its holdings in Doximity by 2.5% during the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company’s stock worth $160,947,000 after purchasing an additional 88,922 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in Doximity by 19.8% in the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock valued at $124,503,000 after purchasing an additional 472,565 shares during the period. Institutional investors own 87.19% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Wells Fargo & Company raised Doximity from an “underweight” rating to an “equal weight” rating and lifted their target price for the stock from $19.00 to $41.00 in a report on Friday, November 8th. Canaccord Genuity Group cut shares of Doximity from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $40.00 to $60.00 in a research note on Wednesday, November 13th. Mizuho started coverage on shares of Doximity in a report on Wednesday, December 4th. They set a “neutral” rating and a $55.00 target price on the stock. Canaccord Genuity Group reiterated a “hold” rating and issued a $60.00 price target (up from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. Finally, Stephens started coverage on Doximity in a research report on Friday, December 20th. They set an “equal weight” rating and a $55.00 price target on the stock. Thirteen investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Doximity has an average rating of “Hold” and a consensus price target of $52.59.

Doximity Stock Performance

NASDAQ DOCS opened at $55.22 on Friday. The firm’s fifty day moving average price is $51.81 and its two-hundred day moving average price is $40.74. The stock has a market cap of $10.31 billion, a PE ratio of 63.47, a PEG ratio of 4.16 and a beta of 1.40. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $61.75.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.